首页 | 本学科首页   官方微博 | 高级检索  
     

阿托伐他汀联合抗血小板药治疗缺血性脑卒中的研究进展
引用本文:禤彩霞,曹传伟,黄载文. 阿托伐他汀联合抗血小板药治疗缺血性脑卒中的研究进展[J]. 国际医药卫生导报, 2011, 17(23): 2960-2962. DOI: 10.3760/cma.j.issn.1007-1245.2011.23.044
作者姓名:禤彩霞  曹传伟  黄载文
作者单位:535000,钦州市第二人民医院
摘    要:目的探讨阿托伐他汀联合抗血小板药治疗缺血性脑卒中患者的疗效与安全性。方法查阅文献,综合论点。结果我国人群中脑卒中患者以缺血性为主,他汀类药物和抗血小板药根据不同的药理机制与脑卒中的一、二级预防有着紧密的联系,结论两者在缺血性脑卒患者中联合使用取得了比单一使用更好的疗效,本文就该种疗法的应用进行综述。

关 键 词:缺血性脑卒中  阿托伐他汀  抗血小板药

Atorvastatin combined with antiplatelet drugs for cerebral ischemic stroke
XUAN Cai-xia,CAO Zhuan-wei,HUANG Zai-wen. Atorvastatin combined with antiplatelet drugs for cerebral ischemic stroke[J]. International Medicine & Health Guidance News, 2011, 17(23): 2960-2962. DOI: 10.3760/cma.j.issn.1007-1245.2011.23.044
Authors:XUAN Cai-xia  CAO Zhuan-wei  HUANG Zai-wen
Affiliation:( The Second People's Hospital of Qinzhou, Qinzhou 535000, China)
Abstract:0bjective To explore the efficacy and safety of atorvastatin combined with antiplatelet drugs for cerebral ischemic stroke.Methods We searched and reviewed literatures and then summarized points.Results and Conclusions China's population-based stroke patients with ischemic,stains and antiplatelet depending on the pharmacological mechanism of stroke and second prevention are closely linked.Both in patients with cerebral ischemic stroke achieved better outcomes than single-use.
Keywords:Atorvastatin  Antiplatelet drugs  Cerebral ischemic stroke
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号